{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:47:33Z","timestamp":1792442853971,"version":"4.5.0"},"reference-count":23,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,5,11]],"date-time":"2015-05-11T00:00:00Z","timestamp":1431302400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD12\/0042\/0068;RS12\/0042\/0010;RD12\/0042\/0069;RD12\/0042\/0049;RD12\/0042\/0063"],"award-info":[{"award-number":["RD12\/0042\/0068;RS12\/0042\/0010;RD12\/0042\/0069;RD12\/0042\/0049;RD12\/0042\/0063"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Cardiology"],"published-print":{"date-parts":[[2015,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Vitamin K antagonists (<jats:styled-content style=\"fixed-case\">VKA<\/jats:styled-content>) have a narrow therapeutic range, and literature analysis reveals poor quality of anticoagulation control. We sought to assess the prevalence of poor anticoagulant control in patients under <jats:styled-content style=\"fixed-case\">VKA<\/jats:styled-content> treatment in the prevention of stroke for atrial fibrillation (<jats:styled-content style=\"fixed-case\">AF<\/jats:styled-content>).<\/jats:p><\/jats:sec><jats:sec><jats:title>Hypothesis<\/jats:title><jats:p>Control of anticoagulation with VKA is inadequate in a high percentage of patients with AF.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Patients with <jats:styled-content style=\"fixed-case\">AF<\/jats:styled-content> under <jats:styled-content style=\"fixed-case\">VKA<\/jats:styled-content> treatment were prospectively recruited in this observational registry. The sample comprised 948 patients. The estimated time spent in the therapeutic range (<jats:styled-content style=\"fixed-case\">TTR<\/jats:styled-content>) was calculated, and variables related with a <jats:styled-content style=\"fixed-case\">TTR<\/jats:styled-content> &gt;65% were analyzed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Mean age was 73.8 \u00b1 9.4 years, and 42.5% of the patients were women. Mean <jats:styled-content style=\"fixed-case\">TTR<\/jats:styled-content> was 63.77% \u00b1 23.80% for the direct method and 60.27% \u00b1 24.48% for the Rosendaal method. Prevalence of poor anticoagulation control was 54%. Variables associated with good anticoagulation control were university studies (odds ratio [<jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>]: 1.99, 95% confidence interval [<jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>]: 1.08\u20103.64), chronic hepatic disease (<jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>: 8.15, 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>: 1.57\u201042.24), low comorbidity expressed as Charlson index (<jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>: 0.87, 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>: 0.76\u20100.99), no previous cardiac disease (<jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>: 0.64, 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>: 0.41\u20100.98), lower risk of bleeding assessed as hypertension, abnormal renal\/liver function, stroke, bleeding history or predisposition, labile international normalized ratio, elderly age, and use of drugs or alcohol (<jats:styled-content style=\"fixed-case\">HAS\u2010BLED<\/jats:styled-content>; <jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>: 0.81, 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>: 0.69\u20100.95), and lower heart rate (<jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>: 0.99, 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>: 0.98\u20100.99).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Patients who receive <jats:styled-content style=\"fixed-case\">VKA<\/jats:styled-content> to prevent stroke for <jats:styled-content style=\"fixed-case\">AF<\/jats:styled-content> spend less than half the time within therapeutic range.<\/jats:p><\/jats:sec>","DOI":"10.1002\/clc.22397","type":"journal-article","created":{"date-parts":[[2015,5,11]],"date-time":"2015-05-11T13:07:11Z","timestamp":1431349631000},"page":"357-364","source":"Crossref","is-referenced-by-count":67,"title":["Quality of Anticoagulation With Vitamin K Antagonists"],"prefix":"10.1002","volume":"38","author":[{"given":"Vicente","family":"Bertomeu\u2010Gonz\u00e1lez","sequence":"first","affiliation":[{"name":"Department of Cardiology San Juan University Hospital, Miguel Hern\u00e1ndez University  Alicante Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Anguita","sequence":"additional","affiliation":[{"name":"Department of Cardiology Research Agency of the Spanish Society of Cardiology  Madrid Spain"},{"name":"Department of Cardiology University Hospital Reina Sof\u00eda  C\u00f3rdoba Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Moreno\u2010Arribas","sequence":"additional","affiliation":[{"name":"Department of Cardiology San Juan University Hospital, Miguel Hern\u00e1ndez University  Alicante Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel","family":"Cequier","sequence":"additional","affiliation":[{"name":"Department of Cardiology Research Agency of the Spanish Society of Cardiology  Madrid Spain"},{"name":"Department of Cardiology Bellvitge University Hospital, L'Hospitalet de Llobregat  Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Mu\u00f1iz","sequence":"additional","affiliation":[{"name":"Department of Cardiology University Institute in Health Sciences, University of A Coru\u00f1a, A Coru\u00f1a Biomedical Research Institute  A Coru\u00f1a Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Castillo\u2010Castillo","sequence":"additional","affiliation":[{"name":"Department of Cardiology San Juan University Hospital, Miguel Hern\u00e1ndez University  Alicante Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Sanchis","sequence":"additional","affiliation":[{"name":"Department of Cardiology Hospital Clinic of Val\u00e8ncia, University of Valencia  Valencia Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"Rold\u00e1n","sequence":"additional","affiliation":[{"name":"Department of Cardiology University Hospital La Paz  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Marin","sequence":"additional","affiliation":[{"name":"Department of Cardiology University Hospital Virgen de la Arrixaca  Murcia Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Bertomeu\u2010Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Department of Cardiology San Juan University Hospital, Miguel Hern\u00e1ndez University  Alicante Spain"},{"name":"Department of Cardiology Research Agency of the Spanish Society of Cardiology  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the FANTASIIA Study Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,5,11]]},"reference":[{"key":"e_1_2_6_2_1","first-page":"486","article-title":"Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients","volume":"15","author":"Wilke T","year":"2013","journal-title":"Eur Soc Cardiol"},{"key":"e_1_2_6_3_1","first-page":"12","article-title":"Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta\u2010analysis and meta\u2010regression","volume":"24","author":"Mearns ES","year":"2014","journal-title":"Thromb J."},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.129.5.1155"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.108.796185"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2009.15.3.244"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp080507"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-1584"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-0134"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(87)90171-8"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1651587"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.750000"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.13-0054"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/clc.22206"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.21.2639"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.737312"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.recesp.2013.03.006"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.recesp.2014.01.015"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2014.07.016"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH13-12-1007"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(97)90048-6"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1556"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2005.02.038"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-006-5580-y"}],"container-title":["Clinical Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fclc.22397","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/clc.22397","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T21:24:01Z","timestamp":1696281841000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/clc.22397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,11]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["10.1002\/clc.22397"],"URL":"https:\/\/doi.org\/10.1002\/clc.22397","archive":["Portico"],"relation":{},"ISSN":["0160-9289","1932-8737"],"issn-type":[{"value":"0160-9289","type":"print"},{"value":"1932-8737","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,11]]}}}